Pharma and Med-Tech: PR Insights from the Early Christmas Blitz

early-christmas-shopping

The holiday season is upon us. And with it another season’s worth of dismay at how early it starts. One minute you’re sneaking your kids’ Halloween candy, and the next you’re face to face with Santa at the mall after some time warp transported you into the holidays nearly two months ahead of time. It’s enough to turn anyone into a Grinch. But pharmaceutical and med-tech companies could take a cue from retail in this instance, because the time to prepare for a product’s commercialization is not just two months – but at least two years – before FDA approval.

That’s right. At least two years to “seed the market” for your product’s success. Here are five PR insights about what that entails.

Shifting your mindset.

Research is what gets you to “the next big thing,” so understandably that’s where your focus has been. But preparing for commercialization requires you to move from that singular goal/singular audience mindset to more “multi-level thinking.” Who needs to know about us? Where do we need to be seen? What publications do we need to be in? Before the market can trust in your product, it has to trust in you – your science, your reputation and your story. Start thinking about building that trust now.

Knowing the playing field.

Who are or will be your main competitors? How do they differentiate and market themselves? What industry trends, obstacles and opportunities are on the horizon that could influence the commercialization of your product? Do your research and illuminate the battlefield upon which you’ll find yourself deployed so you can show up armed and ready for business.

Expanding your circle of influence. 

During the research and pre-commercial development phase, your primary audiences tend to be the scientific and regulatory communities. To prepare for commercialization, you need to expand your circle of influence and build relationships with the industry’s key opinion leaders, policymakers, providers and patient organizations. This also requires creating an advisory board of these influencers to help move your organization forward. Understanding and building relationships with those critical to your success – before you need them – creates a fertile environment for your product’s success.

Getting your communications house in order.

There’s a lot of work that has to happen before you issue that much awaited press release:  We work with clients to create their own “newsroom” to drive and leverage the content necessary for successful commercialization; the three pillars of which are:

Planning for the worst

That’s right. No matter how sound your science is and how well your clinical trials are going, every company needs a crisis plan. Whether there is an adverse patient outcome, or simply a delay in FDA approval, your ability to handle a crisis directly correlates with how well your company recovers from it. Plan for the worst, strive for the best. You’ll rest easier in between.

So the next time you bristle at the sight of candy canes next to the candy corn (or maybe next year, back to school supplies), remember…if you’re a pharmaceutical or med-tech company with promising products in the pipeline, it’s not too early to have visions of a successful commercialization dancing in your head. Preparation will be the gift that keeps on giving.

Related Posts: Go Big or Go Home – How Halloween Marketing Can Impact Your Bottom Line A Guide to Holiday Social Campaigns How the FDA Won Halloween with Black Licorice The Need for Pharma to Fearlessly Innovate in Social Media Communicating Along the Regulatory Runway Halloween 2020: The Treats are Alive